1887

n Southern African Journal of HIV Medicine - Management of HIV-Hepatitis B co-infection : guideline

Volume 12, Issue 1
  • ISSN : 1608-9693
USD

 

Abstract

HIV-hepatitis B virus (HBV) co-infected patients are at risk of increased morbidity and mortality. Early recognition of dual infection is a critical factor in directing appropriate therapy, and HBV screening should therefore be undertaken at the time of HIV diagnosis. Vaccination against HBV should be considered for all HIV patients who are not yet infected with HBV. Antiretroviral therapy containing two antiretrovirals active against HBV should be started if the patient either has symptomatic liver disease or is asymptomatic with a CD4 count of <350 cells/µl.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/m_sajhiv/12/1/EJC65550
2011-04-01
2016-12-10

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error